High‐Flow Nasal Cannula Versus Conventional Oxygen Therapy in Patients Undergoing Thoracic Surgery: A Randomized Controlled Trial
HFNC, applied during intubation and extubation, did not significantly reduce the incidence of PPC or secondary outcomes compared to conventional oxygen therapy in patients undergoing elective thoracic surgery. Further research is needed to explore HFNC's potential in high-risk populations or with optimized protocols, such as extended application periods or varied flow rates, to enhance perioperative respiratory management.
Authors
- Louise M. Corbellini
- Desiré Tarso Maioli
- Cintia L. Santos
- Cristiano F. Andrade
- Clovis T. Bevilacqua Filho
- Andre P. Schmidt
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Instituto Federal de Educação, Ciência e Tecnologia do Rio Grande do Sul (BR)
- Hospital de Clínicas de Porto Alegre (BR)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/1759-7714.70251
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00